Both tacrolimus and sirolimus decrease Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion (Q46135706)

19 December 2017

title

Both tacrolimus and sirolimus decrease Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion (English)

1 reference

19 December 2017

1 reference

Eva Jiménez

5

0 references

Javier Arias-Díaz

object named as

Javier Arias-Diaz

1

0 references

Agustín G Zapata

object named as

Agustín Zapata

4

0 references

author name string

José A Ildefonso

2

1 reference

19 December 2017

Juan J Muñoz

3

1 reference

19 December 2017

publication date

2 February 2009

1 reference

19 December 2017

published in

Laboratory Investigation

1 reference

19 December 2017

volume

89

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

433-445

1 reference

19 December 2017

CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Rat peripheral CD4+CD8+ T lymphocytes are partially immunocompetent thymus-derived cells that undergo post-thymic maturation to become functionally mature CD4+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Development and function of CD25+CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

B cell deficiency confers protection from renal ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Early activation of gammadelta T lymphocytes in patients with severe systemic inflammatory response syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Physiological responses of extrathymic T cells in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Involvement of natural killer T cells and granulocytes in the inflammation induced by partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Apoptosis and necrosis in the liver: a tale of two deaths?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

The liver as an immunological organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

G-CSF-induced evacuation of sinusoidal NK cells and the facilitation of liver regeneration in a partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

FK506 (tacrolimus) inhibits extravasation of lymphoid cells by abrogating VLA-4/VCAM-1 mediated transendothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

T cells as mediators in renal ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Stimulation of Na,K-ATPase by low potassium requires reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Regulatory T cells and intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Enhanced regulatory T cell activity is an element of the host response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

A function for interleukin 2 in Foxp3-expressing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Cytoprotective effect of somatostatin in a rat model of hepatic ischemic reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Functional activity of natural antibody is altered in Cr2-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

A novel cell type carrying both Th and Tc/s markers in the blood of cyclosporine-treated, allografted rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Ciclosporin aggravates tissue damage in ischemia reperfusion-induced acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Clonal expansion of superantigen-reactive T cells is resistant to FK506 in mice with AIDS

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Hepatocellular apoptosis during Candida albicans colonization: involvement of TNF-alpha and infiltrating Fas-L positive lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

FK506 promotes liver regeneration by suppressing natural killer cell activity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Regulation of liver regeneration by interleukin-2 and its inhibitors: Cyclosporine A and FK 506

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

CD4+CD25+ regulatory T cells control innate immune reactivity after injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.3

7 January 2021

Identifiers

DOI

10.1038/LABINVEST.2009.3

1 reference

19 December 2017

1 reference

19 December 2017